Mean corneal neovascularization area at week 52 ( visit 12 ) was 2.321.79 % in treatment group A versus placebo ( 2.792.11 % ; P = 0.45 ) and 2.742.22 % in treatment group B versus placebo ( 2.792.11 % ; P = 0.94 ) .